Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript November 6, 2024Amphastar Pharmaceuticals, Inc. misses on earnings expectations.
Amphastar Pharmaceuticals Inc. (AMPH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 568,494 | $27,589,013 | +151% | 0.03% |
| 2. | Renaissance Technologies Jim Simons | 489,400 | $23,750,582 | -9% | 0.03% |
| 3. | 18,400,000 | $19,521,212 | 0.55% | ||
| 4. | Portolan Capital Management George Mccabe | 327,764 | $15,906,387 | +202% | 1.15% |
| 5. | Boone Capital Daniel Walter Boone Iv | 316,556 | $15,362,463 | -37% | 3.98% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.26 | 1,000 | Director | 13,151 | 2020-08-14 | Filing | |
| $16.06 | 15,000 | Large Shareholder, Officer, Director | 2,080,619 | 2018-05-16 | Filing | |
| $16.08 | 25,000 | Large Shareholder, Officer, Director | 2,065,619 | 2018-05-15 | Filing | |
| $10.84 | 6,000 | Director | 101,215 | 2014-08-25 | Filing | |
| $10.00 | 3,500 | Director | 17,639 | 2014-08-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $48.88 | 6,893 | 118,388 | 2024-11-12 | Filing | ||
| $48.80 | 5,000 | 31,471 | 2024-11-12 | Filing | ||
| $52.05 | 5,214 | 74,938 | 2024-11-06 | Filing | ||
| $52.05 | 7,426 | 94,103 | 2024-11-06 | Filing | ||
| $48.26 | 3,000 | 118,388 | 2024-09-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,037,158 | $373,398,223 | 0% | |
| 2. | 3,272,761 | $202,420,268 | 0.5% | |
| 3. | 2,815,596 | $174,144,612 | 0% | |
| 4. | 1,693,002 | $104,712,174 | 0.09% | |
| 5. | 1,471,137 | $90,989,823 | 0% |
News See All
Piper Sandler's Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets. September's second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Amphastar Pharmaceuticals' First Quarter Earnings Call. At this time, all participants are in a listen-only mode.
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Amphastar Pharmaceuticals fourth quarter earnings call.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Amphastar Pharmaceuticals Third Quarter Earnings Conference Call.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Amphastar Pharmaceuticals Second Quarter Earnings Call. At this time, all participants are in a listen-only mode.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Amphastar Pharmaceuticals, Inc. First Quarter Earnings Call.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to the Amphastar Pharmaceuticals Fourth Quarter Earnings Call. At this time all participants are in a listen-only mode.